152 related articles for article (PubMed ID: 38285890)
21. The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization.
Miranda E; Ferrarotti I; Berardelli R; Laffranchi M; Cerea M; Gangemi F; Haq I; Ottaviani S; Lomas DA; Irving JA; Fra A
FEBS J; 2017 Jul; 284(13):2110-2126. PubMed ID: 28504839
[TBL] [Abstract][Full Text] [Related]
22. A Novel Small Molecule Inhibits Intrahepatocellular Accumulation of Z-Variant Alpha 1-Antitrypsin In Vitro and In Vivo.
Zhang X; Pham K; Li D; Schutte RJ; Gonzalo DH; Zhang P; Oshins R; Tan W; Brantly M; Liu C; Ostrov DA
Cells; 2019 Dec; 8(12):. PubMed ID: 31817705
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1-antitrypsin.
Baligar P; Kochat V; Arindkar SK; Equbal Z; Mukherjee S; Patel S; Nagarajan P; Mohanty S; Teckman JH; Mukhopadhyay A
Hepatology; 2017 Apr; 65(4):1319-1335. PubMed ID: 28056498
[TBL] [Abstract][Full Text] [Related]
24. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
Teckman JH
COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
[TBL] [Abstract][Full Text] [Related]
25. FBG1 Is the Final Arbitrator of A1AT-Z Degradation.
Wen JH; Wen H; Gibson-Corley KN; Glenn KA
PLoS One; 2015; 10(8):e0135591. PubMed ID: 26295339
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.
Karatas E; Raymond AA; Leon C; Dupuy JW; Di-Tommaso S; Senant N; Collardeau-Frachon S; Ruiz M; Lachaux A; Saltel F; Bouchecareilh M
JHEP Rep; 2021 Aug; 3(4):100297. PubMed ID: 34151245
[TBL] [Abstract][Full Text] [Related]
27. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
[TBL] [Abstract][Full Text] [Related]
28. The Recruitment-Secretory Block ("R-SB") Phenomenon and Endoplasmic Reticulum Storage Diseases.
Callea F; Tomà P; Bellacchio E
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202771
[TBL] [Abstract][Full Text] [Related]
29. Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.
Guo S; Booten SL; Aghajan M; Hung G; Zhao C; Blomenkamp K; Gattis D; Watt A; Freier SM; Teckman JH; McCaleb ML; Monia BP
J Clin Invest; 2014 Jan; 124(1):251-61. PubMed ID: 24355919
[TBL] [Abstract][Full Text] [Related]
30. Autophagy master regulator TFEB induces clearance of toxic SERPINA1/α-1-antitrypsin polymers.
Pastore N; Ballabio A; Brunetti-Pierri N
Autophagy; 2013 Jul; 9(7):1094-6. PubMed ID: 23584152
[TBL] [Abstract][Full Text] [Related]
31. A transgenic zebrafish model of hepatocyte function in human Z α1-antitrypsin deficiency.
Yip E; Giousoh A; Fung C; Wilding B; Prakash MD; Williams C; Verkade H; Bryson-Richardson RJ; Bird PI
Biol Chem; 2019 Nov; 400(12):1603-1616. PubMed ID: 31091192
[TBL] [Abstract][Full Text] [Related]
32. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo.
Khodayari N; Oshins R; Holliday LS; Clark V; Xiao Q; Marek G; Mehrad B; Brantly M
Cell Commun Signal; 2020 Sep; 18(1):140. PubMed ID: 32887613
[TBL] [Abstract][Full Text] [Related]
33. Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin Deficiency.
Li J; Moretti F; Hidvegi T; Sviben S; Fitzpatrick JAJ; Sundaramoorthi H; Pak SC; Silverman GA; Knapp B; Filipuzzi I; Alford J; Reece-Hoyes J; Nigsch F; Murphy LO; Nyfeler B; Perlmutter DH
Cell Mol Gastroenterol Hepatol; 2024; 17(6):1007-1024. PubMed ID: 38336172
[TBL] [Abstract][Full Text] [Related]
34. Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease.
Wooddell CI; Blomenkamp K; Peterson RM; Subbotin VM; Schwabe C; Hamilton J; Chu Q; Christianson DR; Hegge JO; Kolbe J; Hamilton HL; Branca-Afrazi MF; Given BD; Lewis DL; Gane E; Kanner SB; Teckman JH
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32379724
[TBL] [Abstract][Full Text] [Related]
35. Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiency.
Wang Y; Perlmutter DH
Pediatr Res; 2014 Jan; 75(1-2):133-9. PubMed ID: 24226634
[TBL] [Abstract][Full Text] [Related]
36. Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases.
Callea F; Francalanci P; Giovannoni I
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071368
[TBL] [Abstract][Full Text] [Related]
37. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
[TBL] [Abstract][Full Text] [Related]
38. Anti-apoptotic effects of Z alpha1-antitrypsin in human bronchial epithelial cells.
Greene CM; Miller SD; Carroll TP; Oglesby IK; Ahmed F; O'Mahony M; Taggart CC; McElvaney NG; O'Neill SJ
Eur Respir J; 2010 May; 35(5):1155-63. PubMed ID: 19840955
[TBL] [Abstract][Full Text] [Related]
39. Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency.
Belchamber KBR; Walker EM; Stockley RA; Sapey E
Int J Chron Obstruct Pulmon Dis; 2020; 15():3183-3192. PubMed ID: 33311976
[TBL] [Abstract][Full Text] [Related]
40. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]